Brett Logan Ecker MD
Surgical Oncology (Other than Breast)
Assistant Professor of Surgery I Rutgers Cancer Institute of New Jersey I Rutgers Robert Wood Johnson Medical School
Join to View Full Profile
94 Old Short Hills RoadSuite 1172Livingston, NJ 07039
Dr. Ecker is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Complex General Surgical Oncology, 2020 - 2022
University of Pennsylvania Health SystemResidency, Surgery, 2013 - 2020
Icahn School of Medicine at Mount SinaiClass of 2013
Certifications & Licensure
NJ State Medical License 2022 - 2027
NY State Medical License 2019 - 2022
PA State Medical License 2016 - 2021
American Board of Surgery Surgery- American Board of Surgery Complex General Surgical Oncology
Publications & Presentations
PubMed
- Defining the surgical workforce for colorectal cancer liver metastases: Impact on access to curative care.Vasileios Tsagkalidis, Elizabeth A Handorf, Benjamin A Bates, David G Brauer, Charu Verma
Surgery. 2025-07-22 - ASO Visual Abstract: Estimating the Survival Impact of Curative-Intent Liver Therapies for Colorectal Cancer Liver Metastases.Vasileios Tsagkalidis, Elizabeth A Handorf, Benjamin A Bates, David G Brauer, Patrick M Boland
Annals of Surgical Oncology. 2025-06-05 - ASO Author Reflections: Improved Access, Improved Outcomes: Regional Increases of Curative-Intent Liver Therapies Are Associated with Improved Survival in Patients wit...Vasileios Tsagkalidis, Brett L Ecker
Annals of Surgical Oncology. 2025-06-02
Authored Content
- Impact of Operative Time on Outcomes After Pancreatic Resection: A Risk-Adjusted Analysis Using the American College of Surgeons NSQIP DatabaseFebruary 2018
Press Mentions
- Age Is a Primary Determinant of Melanoma Treatment Resistance, Two Studies FindNovember 3rd, 2020
- Two New Studies Suggest Age Is A Primary Determinant of Melanoma Treatment ResistanceNovember 2nd, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
